Docecon
On the Bulgarian pack: Доцекон 20 mg/ml концентрат за инфузионен разтвор
20 mg/ml · concentrate for solution for infusion
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Docetaxel
- Made by
- Farmakons AD
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet read the official leaflet for this product. The exact uses and dose are in the leaflet inside the pack. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States15 matching products
European UnionNo exact match for this strength and form
Spain11 matching products
- DOCETAXEL KABI 20 mg/ml · concentrado para solución para perfusión2 makers
- TAXOTERE 20 mg/ml de doxetacel · concentrado para solución para perfusión2 makers
- DOCETAXEL AUROVIT 20 mg/ml · concentrado para solución para perfusión
- DOCETAXEL AUROVITAS 20 mg/ml · concentrado para solución para perfusión
- DOCETAXEL GLENMARK 20 mg/ml · concentrado para solución para perfusión
- DOCETAXEL SEACROSS 20 mg/ml · concentrado para solución para perfusión
- DOCETAXEL TEVA 20 mg · concentrado y disolvente para solución para perfusión
- DOCETAXEL TILLOMED 20 mg/ml · concentrado para solución para perfusión
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Farmakons AD · Bulgaria |
|---|---|
| Active substance | Docetaxel |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 20 mg/ml |
| Form | concentrate for solution for infusion |
| Pack sizes | 1 |
| Classification | L01CD02 · Cancer treatments and immune-system medicines |
| Name in the register | Доцекон 20 mg/ml концентрат за инфузионен разтвор |
| Reg. no. | 20250122 |
Source: Bulgarian Drug Agency register · 2026-08-01 · not reviewed by a clinician
Източник: Изпълнителна агенция по лекарствата (ИАЛ). The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.